We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Smartphone App Offers Alternative to CV Ultrasound Scan

By HospiMedica International staff writers
Posted on 13 Sep 2017
The results of a clinical trial have shown that a new smartphone application, together with the phone’s camera, can be used to effectively measure blood-flow pressure waveforms in the cardiovascular system.

The technique that provides detailed information about cardiac health, involves simply holding a smartphone over the neck of the patient for one or two minutes. More...
This compares with a 45-minute echocardiography ultrasound scan, or a costly Magnetic Resonance Imaging (MRI) scan for measuring the Left Ventricular Ejection Fraction (LVEF).

The results of the proof-of-concept clinical trial were published by researchers from the California Institute of Technology (Caltech), Huntington Medical Research Institute (Pasadena, CA, USA) and the University of Southern California (USC; Los Angeles, CA, USA), in the July 2017 issue of the journal Critical Care Medicine.

The new technique measures how much the carotid artery displaces the skin on the neck during a heartbeat, and infers the cardiac LVEF. The study included 72 volunteer patients all of whom underwent the smartphone LVEF exam, followed by an MRI LVEF exam. The data from both exams were compared, and showed a margin of error for the smartphone exam that was less than that for LVEF using echocardiography. The technique could also be used in the future to diagnose aortic stenosis, coronary artery blockages, and other heart valve diseases.

Senior author of a paper on the study, Mory Gharib (PhD '83), Caltech, said, "In a surprisingly short period of time, we were able to move from invention to the collection of validating clinical data. What is exciting about this study is that it shows our technique is as accurate as echocardiography at estimating LVEF when both are compared to the gold standard of cardiac MRI. This has the potential to revolutionize how doctors and patients can screen for and monitor heart disease both in the U.S. and the developing world."

Related Links:
California Institute of Technology
Huntington Medical Research Institute
University of Southern California

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Premium Air-Mattress
MA-51
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.